220 related articles for article (PubMed ID: 32071398)
1. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.
Zhang G; Tang X; Liang L; Zhang W; Li D; Li X; Zhao D; Zheng Y; Chen Y; Hao B; Wang K; Tang N; Ding K
Oncogene; 2020 Apr; 39(16):3229-3244. PubMed ID: 32071398
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.
Wu Q; Liu HO; Liu YD; Liu WS; Pan D; Zhang WJ; Yang L; Fu Q; Xu JJ; Gu JX
J Biol Chem; 2015 Jan; 290(2):1170-85. PubMed ID: 25422324
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src/PI3K/Akt pathway.
Liu W; Guo TF; Jing ZT; Yang Z; Liu L; Yang YP; Lin X; Tong QY
FASEB J; 2018 Jun; 32(6):3033-3046. PubMed ID: 29401603
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
Liao B; Zhou H; Liang H; Li C
Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612
[TBL] [Abstract][Full Text] [Related]
5. Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
Tu W; Yang B; Leng X; Pei X; Xu J; Liu M; Dong Q; Tao D; Lu Y; Liu Y; Yang Y
Cancer Sci; 2019 May; 110(5):1573-1586. PubMed ID: 30815935
[TBL] [Abstract][Full Text] [Related]
6. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
Bai PS; Hou P; Kong Y
Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
[TBL] [Abstract][Full Text] [Related]
8. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
9. Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
Yan X; Shao C; Chen C; Chen J; Gu S; Huang L; Fu X; Zhao H; Qiu Y
Dig Dis Sci; 2017 Feb; 62(2):407-417. PubMed ID: 28058595
[TBL] [Abstract][Full Text] [Related]
10. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis.
Lee HS; Rajagopalan MS; Vyas GN
Hepatology; 1988; 8(5):1116-20. PubMed ID: 2843452
[TBL] [Abstract][Full Text] [Related]
11. Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study.
Ding K; Wu S; Ying W; Pan Q; Li X; Zhao D; Li X; Zhao Q; Zhu Y; Ren H; Qian X
Sci Rep; 2015 Dec; 5():17564. PubMed ID: 26631547
[TBL] [Abstract][Full Text] [Related]
12. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway.
Liu H; Xu J; Zhou L; Yun X; Chen L; Wang S; Sun L; Wen Y; Gu J
Cancer Res; 2011 Dec; 71(24):7547-57. PubMed ID: 21994334
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
[TBL] [Abstract][Full Text] [Related]
15. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
16. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
17. Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.
Chen Y; Wang L; Xu H; Liu X; Zhao Y
Oncol Rep; 2013 Oct; 30(4):1906-12. PubMed ID: 23912677
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
20. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]